FDA Device Intelligence
Home › HARDY DIAGNOSTICS › HardyDisk™

HardyDisk™

HARDY DIAGNOSTICS · Model Z9461 · UDI-DI 00819398020732

JTN Prescription
1
510(k) clearances
35
Adverse events
47
Recalls
11
Facilities

Description

Sulbactam / Durlobactam 10 /10 µg (SUD20), 1 x 50 disks, used for semi-quantitative in vitro susceptibility testing by the agar diffusion test procedure (Kirby- Bauer) of rapidly growing and certain fastidious bacterial pathogens when there is the need to determine the susceptibility of microorganisms to Sulbactam / Durlobactam. Product can be used to determine the zone diameter (mm) of Sulbactam / Durlobactam against the following microorganisms for which Sulbactam / Durlobactam has been shown to be active both clinically and in vitro: Acinetobacter baumannii-calcoaceticus complex (ABC).

Recalls

DateFirmReason
2026-06-08Hardy DiagnosticsDue to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an
2024-12-23Oxoid LimitedMislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
2024-11-06Becton Dickinson & Co.BD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may result in falsely r
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result
2024-01-08Becton Dickinson & Co.There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed result

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.